In which disease is there a deficiency of the enzyme galactocerebrosidase?

Krabbe Disease, also known as globoid cell leukodystrophy, is characterized by a deficiency in the enzyme galactocerebrosidase. This enzyme is crucial for the breakdown of galactocerebroside, a type of lipid found in the myelin sheath of nerve cells. When galactocerebrosidase is deficient, toxic metabolites accumulate, leading to demyelination and severe neurological symptoms.

Individuals with Krabbe Disease typically present in infancy with signs of irritability, developmental delay, and progressive loss of motor skills. The accumulation of psychosine, a toxic substrate due to the enzyme deficiency, contributes to the disease's pathogenesis. Early identification through newborn screening and understanding of the enzyme's role can help guide therapeutic interventions.

While other diseases like Gaucher, Sandhoff, and Maple Syrup Urine Disease have distinct enzymatic deficiencies leading to different pathological processes, they do not involve the deficiency of galactocerebrosidase, thus clarifying why Krabbe Disease is the correct choice.